Schedule 13G ownership disclosure

CLEARSIDE BIOMEDICAL INC

Security class unavailable · CUSIP: 185063104

Event date: 2019-01-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
64,044
Percent of class
0.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-19-000026
Form type
SC 13G/A
Filer
Clearside Biomedical, Inc.
CIK
CIK 1539029
Filed
Feb 11, 2019
Reporting period
Jan 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub